BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 59 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,087,408 | -1.6% | 1,120,000 | 0.0% | 0.02% | 0.0% |
Q2 2023 | $1,104,578 | -4.0% | 1,120,000 | 0.0% | 0.02% | -15.4% |
Q1 2023 | $1,150,498 | -83.4% | 1,120,000 | -83.5% | 0.03% | -86.9% |
Q2 2018 | $6,913,000 | +8.1% | 6,800,000 | 0.0% | 0.20% | +6.5% |
Q1 2018 | $6,395,000 | -5.9% | 6,800,000 | 0.0% | 0.19% | -4.6% |
Q4 2017 | $6,794,000 | -14.3% | 6,800,000 | -12.8% | 0.20% | -13.7% |
Q3 2017 | $7,924,000 | – | 7,800,000 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
IRON Financial LLC | 275,000 | $295,000 | 0.15% |
PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |